Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIOMERICA INCBMRA · Entity 8171 | Director | August 26, 2026 | August 27, 2026 |
| Evolus, Inc.EOLS · Entity 5341 | Director · See Remarks | September 02, 2026 | September 04, 2026 |
| Vyome Holdings, IncOBLN · Entity 1824 | Director | July 23, 2019 | July 25, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIOMERICA INC
Report date August 26, 2026 · Filed August 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 40,625 |
Reported balance
After 2026-08-26 transaction · row 1
1 source rowRow 1 · 2026-08-26 · Purchase · Acquired 10,000 · Balance 40,625 F1: On August 26, 2026, the reporting person acquired 10,000 shares of the Issuer's common stock at a purchase price of $1.60 per share in private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated August 20, 2026, by and among certain institutional and individual investors identified on the signature pages thereto, which included among others B. Riley Principal Capital, LLC and certain members of the Company's Board of Directors and executive officers. |
Filing footnotes · ownership attribution and instrument terms
F1: On August 26, 2026, the reporting person acquired 10,000 shares of the Issuer's common stock at a purchase price of $1.60 per share in private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated August 20, 2026, by and among certain institutional and individual investors identified on the signature pages thereto, which included among others B. Riley Principal Capital, LLC and certain members of the Company's Board of Directors and executive officers.
Evolus, Inc.
Report date September 02, 2026 · Filed September 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 499,592 |
Reported balance
After 2026-09-02 transaction · row 1
1 source rowRow 1 · 2026-09-02 · Sale · Disposed 105,108 · Balance 499,592 F1: The shares were sold in multiple trades at prices ranging from $9.00 to $9.13. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were sold in multiple trades at prices ranging from $9.00 to $9.13. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Vyome Holdings, Inc
Report date July 23, 2019 · Filed July 25, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock (Restricted Stock Units)SEC Table I · non-derivative | Direct | 83,619 |
Reported balance
After 2019-07-23 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2019-07-23 · Grant · Acquired 78,125 · Balance 83,619 F1: This award will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the annual meeting of the Issuer's stockholders immediately following the grant date. F2: Share amounts do not reflect the impact of a 1-for-10 reverse stock split that became effective after the grant date for the options referenced herein. |
Filing footnotes · ownership attribution and instrument terms
F1: This award will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the annual meeting of the Issuer's stockholders immediately following the grant date.
F2: Share amounts do not reflect the impact of a 1-for-10 reverse stock split that became effective after the grant date for the options referenced herein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2022 Filed Mar 11, 2022 00:24 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 37,972 | $9.73 | $369,292.89 |
DisclosureSEC source: 0001570562-22-000085 · wf-form4_164695823489876.xml · nonDerivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 553,386 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units. F2 · price: The shares were sold in multiple trades at prices ranging from $9.50 to $9.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 24, 2022 Filed Jan 27, 2022 02:03 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantStock Option (Right to Buy) · Derivative | 310,559 | $0.00 Strike: $5.46 | $0.00 |
DisclosureSEC source: 0001570562-22-000055 · wf-form4_164324899548076.xml · derivative · entry 2 MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,559 Underlying: Common Stock · 310,559 shares Expires 2032-01-25 F2 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 24, 2022, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 24, 2022 Filed Jan 27, 2022 02:03 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 214,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-22-000055 · wf-form4_164324899548076.xml · nonDerivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 591,358 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 24, 2022, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 00:24 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 47,737 | $11.35 | $541,738.57 |
DisclosureSEC source: 0001570562-21-000161 · wf-form4_162924625650402.xml · nonDerivative · entry 2 MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,072 F2 · price: The shares were sold in multiple trades at prices ranging from $11.156 to $11.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 13, 2021 Filed Aug 18, 2021 00:24 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 22,708 | $10.66 | $242,071.82 |
DisclosureSEC source: 0001570562-21-000161 · wf-form4_162924625650402.xml · nonDerivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,809 F1 · price: The shares were sold in multiple trades at prices ranging from $10.65 to $10.725. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 23:05 UTC Amendment | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 41,763 | $11.18 | $466,839.34 |
DisclosureSEC source: 0001570562-21-000157 · wf-form4a_162880948863025.xml · nonDerivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 447,517 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in the second quarter of 2020 and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units. F2 · price: The shares were sold in multiple trades at prices ranging from $11.1762 to $11.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 22:44 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 41,763 | $11.18 | $466,839.34 |
DisclosureSEC source: 0001570562-21-000153 · wf-form4_162880824304017.xml · nonDerivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 531,043 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in the second quarter of 2020 and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units. F2 · price: The shares were sold in multiple trades at prices ranging from $11.1762 to $11.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 26, 2021 Filed Mar 26, 2021 23:04 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 48,853 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-21-000107 · wf-form4_161679987502835.xml · nonDerivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 489,280 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of March 26, 2021, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 27, 2021 Filed Feb 2, 2021 00:29 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 266,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-21-000017 · wf-form4_161222572441823.xml · nonDerivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440,427 F1 · price: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 27, 2021, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 01:50 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 8,310 | $7.46 | $61,992.60 |
DisclosureSEC source: 0001570562-21-000009 · wf-form4_161171220703468.xml · nonDerivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,760 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in the first quarter of 2020 and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units. Read SEC document |
| May 13, 2020 Filed May 15, 2020 23:59 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-20-000092 · wf-form4_158958714451865.xml · nonDerivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,070 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 100% of the award on July 1, 2021, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 23, 2020 Filed Jan 25, 2020 02:14 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantStock Option (Right to Buy) · Derivative | 141,910 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0001570562-20-000047 · wf-form4_157991844635493.xml · derivative · entry 2 MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,910 Underlying: Common Stock · 141,910 shares Expires 2030-01-23 F2 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 23, 2020 Filed Jan 25, 2020 02:14 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 82,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-20-000047 · wf-form4_157991844635493.xml · nonDerivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,070 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 20:30 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantCommon Stock (Restricted Stock Units) | 78,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-19-004759 · marketforms-45356.xml · nonDerivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,619 F1 · shares: This award will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the annual meeting of the Issuer's stockholders immediately following the grant date. F2 · balance_after: Share amounts do not reflect the impact of a 1-for-10 reverse stock split that became effective after the grant date for the options referenced herein. Read SEC document |
| January 23, 2019 Filed Jan 26, 2019 01:20 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $16.19 | $0.00 |
DisclosureSEC source: 0001570562-19-000023 · wf-form4_154846563955209.xml · derivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2029-01-23 F1 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 23, 2019, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| August 23, 2018 Filed Aug 28, 2018 01:31 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantCommon Stock | 5,494 | $1.82 | $9,999.08 |
DisclosureSEC source: 0001214659-18-005733 · marketforms-42795.xml · nonDerivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,494 F1 · shares: The reporting person purchased these shares directly from the issuer in a private placement. Read SEC document |
| June 13, 2018 Filed Jun 14, 2018 23:51 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantStock Option (Right to Buy) · Derivative | 81,774 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001214659-18-004464 · marketforms-42277.xml · derivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,774 Underlying: Common Stock · 81,774 shares Expires 2028-06-13 F1 · derivative.exercise_date: This Option becomes exercisable with respect to 100% of the Shares subject to this Option on the earlier of (i) the one-year anniversary of the Date of Grant or (ii) the date of the annual meeting of the Company's stockholders immediately following the Date of Grant. Read SEC document |
| June 13, 2018 Filed Aug 29, 2018 20:58 UTC Amendment | Vyome Holdings, Inc OBLN · Entity 1824 | GrantStock Option (Right to Buy) · Derivative | 81,774 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001214659-18-005787 · marketforms-42814.xml · derivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,774 Underlying: Common Stock · 81,774 shares Expires 2028-06-13 F1 · derivative.exercise_date: This amended Form 4 is being filed solely to attach a Power of Attorney for the Reporting Person that was inadvertently omitted from the original Form 4 filing. Reference is made to the original filing for the option vesting terms Read SEC document |
| May 06, 2018 Filed May 9, 2018 01:19 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantStock Option (Right to Buy) · Derivative | 1,182,019 | $7.28 Strike: $7.28 | $8,605,098.32 |
DisclosureSEC source: 0001570562-18-000029 · wf-form4_152582874753746.xml · derivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,182,019 Underlying: Common Stock · 1,182,019 shares Expires 2028-05-06 F1 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of May 6, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| June 06, 2017 Filed Jun 17, 2017 01:23 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantStock Option (Right to Buy) · Derivative | 36,554 | $0.00 Strike: $9.81 | $0.00 |
DisclosureSEC source: 0001214659-17-004066 · marketforms-39084.xml · derivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,554 Underlying: Common Stock · 36,554 shares Expires 2027-06-06 F1 · derivative.exercise_date: The option vests as to 100% of the total shares on June 6, 2018, subject to the reporting person's provision of service to the issuer on the vest date. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 23:16 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantStock Option (Right to Buy) · Derivative | 59,988 | $0.00 Strike: $9.55 | $0.00 |
DisclosureSEC source: 0001214659-17-001984 · marketforms-38405.xml · derivative · entry 1 MOATAZEDI DAVID · CIK 0001700836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,988 Underlying: Common Stock · 59,988 shares Expires 2027-03-12 F1 · derivative.exercise_date: The vesting commencement date ("Vesting Commencement Date") of the option is March 13, 2017. The option vests (i) with respect to one-thirty sixth (1/36) of the shares underlying the option on the first month anniversary of the Vesting Commencement Date and (ii) with respect to 1/36th of the shares underlying the option, on each monthly anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person's continued service with the Issuer through the applicable vesting dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.